In the past, patients with the same type of cancer usually received the same type of treatment. For example, if you had stage IV breast cancer, you probably received similar initial chemotherapy treatment as every other patient with stage IV breast cancer.
But people are not all alike, and tumors are not all alike. Thanks to advances in medicine, today we are able to analyze the DNA of individual patients and their specific tumors — using a process called gene sequencing — to help treat cancer more effectively and efficiently.
Using gene sequencing allows our cancer specialists to identify gene abnormalities in many different types of cancer cells — no matter where the cancer is located. This information helps us to create a truly personalized treatment plan that will work best for you.
Personalized Medicine has been shown to provide improved outcomes for our patients and has quickly become the standard of care we apply to all our patients who come to us for cancer treatment.
Turnaround time for the genetic testing can be as short as one to two weeks, and normally does not delay patients from starting their treatment in any way.
Personalized medicine and gene sequencing is available for our newly diagnosed patients, and is an important piece of the work we do to create the right treatment plan for each patient. It is available for patients of all ages and with all cancer types. And, while not every tumor has an actionable genetic result, most do.
If you have been diagnosed with cancer, your MultiCare doctor will discuss personalized medicine with you in detail when you meet to discuss the next steps for your treatment.
Not a MultiCare patient? Find a MultiCare cancer specialist in your area.
Learn more about Personalized Medicine at these sites: